Quest Corp (DGX): יחס חוב לטווח ארוך להון

This price chart, which assists in the fundamental valuation of Quest Diagnostics (DGX), a company specializing in laboratory diagnostics, shows the 0.78 indicator. The business remains independent of economic cycles and macroeconomic shocks due to medical insurance. Risks are limited solely to a potential shortage of Asian reagents. Meanwhile, a streamlined courier delivery system for biomaterials ensures the uninterrupted operation of the center network and eliminates supply chain disruptions.

Quest Diagnostics bases its development on the aggressive acquisition of local laboratories to scale testing volumes and optimize costs. The ratio of long-term liabilities to equity within the dynamics of long-term debt-to-capital allows for an assessment of debt service risk amid changes in asset market value, determining the balance between financial stability and the pace of business expansion.